ELV Q3 2022 Earnings — Elevance Health Inc. Revenue & Financial Results | Market Cap Arena

ELVElevance Health Inc.

$64B

Q3 2022 Earnings

Healthcare Medical - Healthcare Plans

Income Statement

Revenue

$39.9B+11.5% YoY

Gross Profit

$10.5B26.3% margin

Operating Income

$2.3B5.9% margin

Net Income

$1.6B4.0% margin

EPS (Diluted)

$6.62

QoQ Revenue Growth

+3.4%

Cash Flow

Operating Cash Flow

$4.9B

Free Cash Flow

$4.6B

Stock-Based Comp.

$69M

Balance Sheet

Total Assets

$103.0B

Total Liabilities

$67.0B

Stockholders' Equity

$36.0B

Cash & Equivalents

$8.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$39.9B	$35.8B	+11.5%
Gross Profit	$10.5B	$9.2B	+14.6%
Operating Income	$2.3B	$2.2B	+6.5%
Net Income	$1.6B	$1.5B	+6.2%

Revenue Segments

Government Business Segment

$24.6B54%

Commercial Specialty Business Segment

$10.5B23%

IngenioRx Segment

$7.2B16%

Other Segment

$3.4B7%